COVID-19's impact to Global ALK Positive Lung Cancer Treatment Market Research Report 2020, Forecast to 2025

SKU ID :MMI-16052729 | Published Date: 04-Aug-2020 | No. of pages: 132
Table of Contents Global ALK Positive Lung Cancer Treatment Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 ALK Positive Lung Cancer Treatment Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 ALK Positive Lung Cancer Treatment Segment by Type 1.2.1 Crizotinib 1.2.2 Alectinib 1.2.3 Ceritinib 1.2.4 Brigatinib 1.2.5 Other 1.3 Market Analysis by Application 1.3.1 Hospital 1.3.2 Clinics 1.3.3 Other 1.4 Overview of Global ALK Positive Lung Cancer Treatment Market 1.4.1 Global ALK Positive Lung Cancer Treatment Revenue (2015-2025) 1.4.2 Global ALK Positive Lung Cancer Treatment Production and Capacity (2015-2025) 1.4.3 North America ALK Positive Lung Cancer Treatment Status and Prospect (2015-2025) 1.4.4 Europe ALK Positive Lung Cancer Treatment Status and Prospect (2015-2025) 1.4.5 Japan ALK Positive Lung Cancer Treatment Status and Prospect (2014-2025) 1.4.6 China ALK Positive Lung Cancer Treatment Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): ALK Positive Lung Cancer Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the ALK Positive Lung Cancer Treatment Industry 1.6.2 ALK Positive Lung Cancer Treatment Business Impact Assessment - Covid-19 1.6.3 Market Trends and ALK Positive Lung Cancer Treatment Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global ALK Positive Lung Cancer Treatment Market Competition by Manufacturer 2.1 Global ALK Positive Lung Cancer Treatment Sales and Market Share by Manufacturer (2018-2020) 2.2 Global ALK Positive Lung Cancer Treatment Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global ALK Positive Lung Cancer Treatment Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 ALK Positive Lung Cancer Treatment Manufacturer Market Share 2.5 Top 10 ALK Positive Lung Cancer Treatment Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into ALK Positive Lung Cancer Treatment Market 2.7 Key Manufacturers ALK Positive Lung Cancer Treatment Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of ALK Positive Lung Cancer Treatment Industry Key Manufacturers 3.1 F. Hoffmann-La Roche 3.1.1 Company Details 3.1.2 Product Information 3.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 F. Hoffmann-La Roche News 3.2 Pfizer 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Pfizer ALK Positive Lung Cancer Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Pfizer News 3.3 Novartis 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Novartis ALK Positive Lung Cancer Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Novartis News 3.4 TP Therapeutics 3.4.1 Company Details 3.4.2 Product Information 3.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 TP Therapeutics News 3.5 Bristol-Myers Squibb 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Bristol-Myers Squibb News 3.6 Eli Lilly and Company 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Eli Lilly and Company News 3.7 Takeda 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Takeda ALK Positive Lung Cancer Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Takeda News 3.8 Beacon Pharma 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Beacon Pharma News 4 Global ALK Positive Lung Cancer Treatment Market Size Categorized by Regions (2015-2020) 4.1 Global ALK Positive Lung Cancer Treatment Sales Market Share by Region 4.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Region (2015-2019) 4.3 Global ALK Positive Lung Cancer Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America ALK Positive Lung Cancer Treatment Market Size Detail 4.4.1 North America ALK Positive Lung Cancer Treatment Sales Growth Rate (2015-2020) 4.4.2 North America ALK Positive Lung Cancer Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe ALK Positive Lung Cancer Treatment Market Size Detail 4.5.1 Europe ALK Positive Lung Cancer Treatment Sales Growth Rate (2015-2020) 4.5.2 Europe ALK Positive Lung Cancer Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan ALK Positive Lung Cancer Treatment Market Size Detail 4.6.1 Japan ALK Positive Lung Cancer Treatment Sales Growth Rate (2015-2020) 4.6.2 Japan ALK Positive Lung Cancer Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China ALK Positive Lung Cancer Treatment Market Size Detail 4.7.1 China ALK Positive Lung Cancer Treatment Sales Growth Rate (2015-2020) 4.7.2 China ALK Positive Lung Cancer Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global ALK Positive Lung Cancer Treatment Market Segment by Type 5.1 Global ALK Positive Lung Cancer Treatment Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global ALK Positive Lung Cancer Treatment Sales and Market Share by Type (2015-2020) 5.1.2 Global ALK Positive Lung Cancer Treatment Revenue and Market Share by Type (2015-2020) 5.2 Crizotinib Sales Growth Rate and Price 5.2.1 Global Crizotinib Sales Growth Rate (2015-2020) 5.2.2 Global Crizotinib Price (2015-2020) 5.3 Alectinib Sales Growth Rate and Price 5.3.1 Global Alectinib Sales Growth Rate (2015-2020) 5.3.2 Global Alectinib Price (2015-2020) 5.4 Ceritinib Sales Growth Rate and Price 5.4.1 Global Ceritinib Sales Growth Rate (2015-2020) 5.4.2 Global Ceritinib Price (2015-2020) 5.5 Brigatinib Sales Growth Rate and Price 5.5.1 Global Brigatinib Sales Growth Rate (2015-2020) 5.5.2 Global Brigatinib Price (2015-2020) 5.6 Other Sales Growth Rate and Price 5.6.1 Global Other Sales Growth Rate (2015-2020) 5.6.2 Global Other Price (2015-2020) 6 Global ALK Positive Lung Cancer Treatment Market Segment by Application 6.1 Global ALK Positive Lung Cancer Treatment Sales Market Share by Application (2015-2020) 6.2 Hospital Sales Growth Rate (2015-2020) 6.3 Clinics Sales Growth Rate (2015-2020) 6.4 Other Sales Growth Rate (2015-2020) 7 ALK Positive Lung Cancer Treatment Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 ALK Positive Lung Cancer Treatment Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global ALK Positive Lung Cancer Treatment Market Forecast 8.1 Global ALK Positive Lung Cancer Treatment Sales, Revenue Forecast 8.1.1 Global ALK Positive Lung Cancer Treatment Sales Growth Rate Forecast (2020-2025) 8.1.2 Global ALK Positive Lung Cancer Treatment Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global ALK Positive Lung Cancer Treatment Price and Trend Forecast (2020-2025) 8.2 Global ALK Positive Lung Cancer Treatment Sales Forecast by Region (2020-2025) 8.2.1 North America ALK Positive Lung Cancer Treatment Sales, Revenue Forecast (2020-2025) 8.2.2 Europe ALK Positive Lung Cancer Treatment Sales, Revenue Forecast (2020-2025) 8.2.3 Japan ALK Positive Lung Cancer Treatment Production, Revenue Forecast (2020-2025) 8.2.4 China ALK Positive Lung Cancer Treatment Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix
List of Tables and Figures Figure ALK Positive Lung Cancer Treatment Picture Table Global ALK Positive Lung Cancer Treatment Sales by Type Figure Global Sales Market Share of ALK Positive Lung Cancer Treatment by Product Type in 2019 Table Breakdown of ALK Positive Lung Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3) Figure ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Crizotinib Picture Figure Alectinib Picture Figure Ceritinib Picture Figure Brigatinib Picture Figure Other Picture Table Global ALK Positive Lung Cancer Treatment Sales by Application Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Application in 2019 Figure Hospital Picture Figure Clinics Picture Figure Other Picture Table ALK Positive Lung Cancer Treatment Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global ALK Positive Lung Cancer Treatment Revenue (Million US$) (2015-2025) Figure Global ALK Positive Lung Cancer Treatment Production (K Units) (2015-2025) Figure North America ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate (2015-2025) Figure Europe ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate (2015-2025) Figure Japan ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate (2014-2025) Figure China ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global ALK Positive Lung Cancer Treatment Sales by Manufacturer (2018-2020) Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Manufacturer in 2019 Table Global ALK Positive Lung Cancer Treatment Revenue by Manufacturer (2018-2020) Figure Global ALK Positive Lung Cancer Treatment Revenue Market Share by Manufacturer in 2019 Table Global ALK Positive Lung Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 ALK Positive Lung Cancer Treatment Manufacturer (Revenue) Market Share in 2019 Figure Top 10 ALK Positive Lung Cancer Treatment Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into ALK Positive Lung Cancer Treatment Market Table Key Manufacturers ALK Positive Lung Cancer Treatment Product Type Table Mergers & Acquisitions Planning Table F. Hoffmann-La Roche Company Profile Figure ALK Positive Lung Cancer Treatment Product Picture and Specifications of F. Hoffmann-La Roche Table ALK Positive Lung Cancer Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Market Share (2018-2020) Table F. Hoffmann-La Roche Main Business Table F. Hoffmann-La Roche Recent Development Table Pfizer Company Profile Figure ALK Positive Lung Cancer Treatment Product Picture and Specifications of Pfizer Table ALK Positive Lung Cancer Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Pfizer ALK Positive Lung Cancer Treatment Market Share (2018-2020) Table Pfizer Main Business Table Pfizer Recent Development Table Novartis Company Profile Figure ALK Positive Lung Cancer Treatment Product Picture and Specifications of Novartis Table ALK Positive Lung Cancer Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis ALK Positive Lung Cancer Treatment Market Share (2018-2020) Table Novartis Main Business Table Novartis Recent Development Table TP Therapeutics Company Profile Figure ALK Positive Lung Cancer Treatment Product Picture and Specifications of TP Therapeutics Table ALK Positive Lung Cancer Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure TP Therapeutics ALK Positive Lung Cancer Treatment Market Share (2018-2020) Table TP Therapeutics Main Business Table TP Therapeutics Recent Development Table Bristol-Myers Squibb Company Profile Figure ALK Positive Lung Cancer Treatment Product Picture and Specifications of Bristol-Myers Squibb Table ALK Positive Lung Cancer Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Market Share (2018-2020) Table Bristol-Myers Squibb Main Business Table Bristol-Myers Squibb Recent Development Table Eli Lilly and Company Company Profile Figure ALK Positive Lung Cancer Treatment Product Picture and Specifications of Eli Lilly and Company Table ALK Positive Lung Cancer Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Eli Lilly and Company ALK Positive Lung Cancer Treatment Market Share (2018-2020) Table Eli Lilly and Company Main Business Table Eli Lilly and Company Recent Development Table Takeda Company Profile Figure ALK Positive Lung Cancer Treatment Product Picture and Specifications of Takeda Table ALK Positive Lung Cancer Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Takeda ALK Positive Lung Cancer Treatment Market Share (2018-2020) Table Takeda Main Business Table Takeda Recent Development Table Beacon Pharma Company Profile Figure ALK Positive Lung Cancer Treatment Product Picture and Specifications of Beacon Pharma Table ALK Positive Lung Cancer Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Beacon Pharma ALK Positive Lung Cancer Treatment Market Share (2018-2020) Table Beacon Pharma Main Business Table Beacon Pharma Recent Development Table Global ALK Positive Lung Cancer Treatment Sales (K Units) by Region (2015-2020) Table Global ALK Positive Lung Cancer Treatment Sales Market Share by Region (2015-2019) Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Region (2015-2019) Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Region in 2018 Table Global ALK Positive Lung Cancer Treatment Revenue (Million US$) by Region (2015-2020) Table Global ALK Positive Lung Cancer Treatment Revenue Market Share by Region (2015-2020) Figure Global ALK Positive Lung Cancer Treatment Revenue Market Share by Region (2015-2020) Figure Global ALK Positive Lung Cancer Treatment Revenue Market Share by Region in 2019 Table Global ALK Positive Lung Cancer Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America ALK Positive Lung Cancer Treatment Sales (K Units) Growth Rate (2015-2020) Figure Europe ALK Positive Lung Cancer Treatment Sales (K Units) Growth Rate (2015-2020) Table Europe ALK Positive Lung Cancer Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan ALK Positive Lung Cancer Treatment Sales (K Units) Growth Rate (2015-2020) Table Japan ALK Positive Lung Cancer Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China ALK Positive Lung Cancer Treatment Sales (K Units) Growth Rate (2015-2020) Table China ALK Positive Lung Cancer Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global ALK Positive Lung Cancer Treatment Sales by Type (2015-2020) Table Global ALK Positive Lung Cancer Treatment Sales Market Share by Type (2015-2020) Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Type in 2019 Table Global ALK Positive Lung Cancer Treatment Revenue by Type (2015-2020) Table Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type (2015-2020) Figure Global ALK Positive Lung Cancer Treatment Revenue Market Share by Type in 2019 Figure Global Crizotinib Sales Growth Rate (2015-2025) Figure Global Crizotinib Price (2015-2020) Figure Global Alectinib Sales Growth Rate (2015-2025) Figure Global Alectinib Price (2015-2020) Figure Global Ceritinib Sales Growth Rate (2015-2025) Figure Global Ceritinib Price (2015-2020) Figure Global Brigatinib Sales Growth Rate (2015-2025) Figure Global Brigatinib Price (2015-2020) Figure Global Other Sales Growth Rate (2015-2025) Figure Global Other Price (2015-2020) Table Global ALK Positive Lung Cancer Treatment Sales Market Share by Application (2015-2020) Figure Global ALK Positive Lung Cancer Treatment Sales Market Share by Application in 2019 Figure Global Hospital Sales Growth Rate (2015-2025) Figure Global Clinics Sales Growth Rate (2015-2025) Figure Global Other Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of ALK Positive Lung Cancer Treatment Table Key Players of Downstream Markets Figure Sales Channel Figure Global ALK Positive Lung Cancer Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure Global ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global ALK Positive Lung Cancer Treatment Price and Trend Forecast (2020-2025) Table Global ALK Positive Lung Cancer Treatment Sales (K Units) Forecast by Region (2020-2025) Figure Global ALK Positive Lung Cancer Treatment Production Market Share Forecast by Region (2020-2025) Figure North America ALK Positive Lung Cancer Treatment Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe ALK Positive Lung Cancer Treatment Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan ALK Positive Lung Cancer Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China ALK Positive Lung Cancer Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure China ALK Positive Lung Cancer Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List
F. Hoffmann-La Roche Pfizer Novartis TP Therapeutics Bristol-Myers Squibb Eli Lilly and Company
  • PRICE
  • $2680
    $4200
    $3800
    Buy Now

Our Clients